Manufacturing will take place at Kyocera’s Vancouver, Wash., facility. The collaboration includes the manufacturing of all FDA-approved Silicon Nitride interbody devices.
The deal will assist Amedica in meeting market demands. The company has sold 14,000 devices worldwide.
More Articles on Devices:
Invibio Launches New Corporate Identity
Intelligent Implant Systems Granted FDA Clearance for Marauder Spine System
Tyber Medical Closes Initial Private Equity Funding Round
